All In Biotech

Drug Trial Radar · NCT06933472

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

A Randomized, Double-Blind, Multi-Regional, Phase 3 Study to Evaluate the Efficacy and Safety of AP301 on Serum Phosphorus Control in Chronic Kidney Disease Patients Receiving Maintenance Dialysis With Hyperphosphatemia

Last checked: Nov 19, 2026Latest source record: Jan 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 264 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

264

Planned (sponsor's estimate)

Start

Jun 13, 2025

Primary completion

Jun 20, 2026

Study completion Jan 10, 2027

Sponsor

Lead sponsor
Alebund PharmaceuticalsIndustry
Sponsor type
Industry
Collaborators
Fortrea
First posted
Apr 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The main questions it aims to answer are: * Does AP301 lower blood phosphate levels? * Does AP301 works on serum calcium level, calcium times phosphate level, and intact parathyroid hormone level? * What discomfort or medical problem do the patients have when taking AP301? * Does AP301 improve quality of life in Chinese patients? The researchers will compare AP301 to an ineffective comparator (a look-alike substance that contains low dose AP301) to see if AP301 works to treat elevated blood phosphate. In the study, the patients will experience the following stages in a chronicle order: * Stop all using blood phosphate-lowering drugs, * Take AP301 or the comparator three times a day for 8 weeks, * Take AP301 three times a day for 24 weeks, and * Take AP301 or the comparator three times a day for 3 weeks. In the first 32 weeks, the dose of AP301 will be adjusted upwards or downwards based on the patient's blood phosphate level and the study doctor's judgment. If the participant has a blood phosphate level above or below a certain level, they may receive additional treatment to lower the blood phosphate level.

Conditions

  • Hyperphosphatemia
  • Chronic Kidney Disease, Receiving Dialysis
  • ESRD (End-Stage Renal Disease)
  • Dialysis

Interventions

  • AP301Drug

    Three times a day, administered orally with three meals at a daily dose level from 2.7g to 9.0g

  • AP301 Low DoseDrug

    Three times a day, administered orally with three meals at a daily dose level from 0.075g to 0.25g

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in serum phosphate concentrations in the AP301 and the AP301 low dose groupsTime frame: From Baseline to the end of Week 8

Locations

42 sites in 2 countries. Site status is shown where the registry gives one.

  • Renal Consultants Medical Group

    Granada Hills, California · Recruiting

  • North America Research Institute - San Dimas

    San Dimas, California · Recruiting

  • North America Research Institute - San Dimas

    San Dimas, California · Recruiting

  • Rocky Mountain Kidney Care - Lone Tree

    Lone Tree, Colorado · Recruiting

  • PACT Kidney Care - Orange

    Orange, Connecticut · Recruiting

  • US Renal Care - Fort Myers South

    Fort Myers, Florida · Recruiting

  • Nephrology & Hypertension Specialists

    Dalton, Georgia · Recruiting

  • Renal Associates Of Baton Rouge, LLC

    Baton Rouge, Louisiana · Recruiting

  • Nephrology Associates, P.C. - Columbus

    Columbus, Mississippi · Recruiting

  • Nephrology & Hypertension Associates Ltd - Tupelo

    Tupelo, Mississippi · Recruiting

  • High Desert Nephrology Association - US Renal Care

    Gallup, New Mexico · Recruiting

  • US Renal Care - West Cheektowaga

    Cheektowaga, New York · Recruiting

  • NY Kidney & Hypertension Medicine

    Ridgewood, New York · Recruiting

  • US Renal Care - Alexis

    Toledo, Ohio · Recruiting

  • Dallas Renal Group - Dallas

    Dallas, Texas · Recruiting

  • US Renal Care - Bluebonnet

    Fort Worth, Texas · Recruiting

  • Gamma Medical Research

    McAllen, Texas · Recruiting

  • US Renal Care - South San Antonio

    San Antonio, Texas · Recruiting

  • US Renal Care - Hill Country

    San Antonio, Texas · Recruiting

  • Peking University First Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Tsinghua Chang Gung Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking University International Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, China · Recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China · Recruiting

  • Zhengzhou University-First Affiliated Hospital

    Zhengzhou, Henan, China · Recruiting

  • Huazhong University of Science and Technology-Tongji Medical College - Wuhan Union Hospital

    Wuhan, Hubei, China · Recruiting

  • Wuhan University People's Hospital

    Wuhan, Hubei, China · Recruiting

  • Central South University-The Third Xiangya Hospital

    Changsha, Hunan, China · Recruiting

  • Southeast University-Zhongda Hospital

    Nanjing, Jiangsu, China · Recruiting

  • Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

    Nanjing, Jiangsu, China · Recruiting

  • Nantong University-Affiliated Hospital

    Nantong, Jiangsu, China · Recruiting

  • Nanjing Medical University-Wuxi People's Hospital (Wuxi No.1 People's Hospital)

    Wuxi, Jiangsu, China · Recruiting

  • Subei People's Hospital

    Yangzhou, Jiangsu, China · Recruiting

  • Jiangxi Provincial People's Hospital

    Nanchang, Jiangxi, China · Recruiting

  • Qingdao University-The Affiliated Hospital

    Qingdao, Shandong, China · Recruiting

  • Yantai Yuhuangding Hospital

    Yantai, Shandong, China · Recruiting

  • Shanghai Jiao Tong University School of Medicine (SJTUSM)-Renji Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Fudan University-Zhongshan Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Fudan University-Huashan Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Children's Hospital of Fudan University

    Shanghai, Shanghai Municipality, China · Not yet recruiting

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.